May 9, 2008
YM Biosciences Reports Fiscal Third Quarter 2008 Operational and Financial Results
“During the quarter we continued to advance nimotuzumab globally, leveraging co-operative efforts of multiple partners and other licensees of the drug”
YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today reported operational and financial results for its third quarter of ... via Med Ad News
Comments
|
Joined: May 11, 2008
Comments: 46
|
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Brain cancer strikes Sen. Kennedy | Aug 13 | the shadow | 42 |
| Vitamin C jabs may combat cancer | Aug 9 | gdpawel | 1 |
| Quartier family mourns death of brave Kailynne (from Aug '07) | Aug 6 | kailynne | 8 |
| Caution on cell phone use | Aug 2 | OWEN | 16 |
| Benefit pasta dinner set for cancer patient | Jul 21 | dick william... | 1 |
| Letter writer sticks up for care at Veterans Af... | Jul '08 | Mutant | 1 |
| Kennedy to the rescue | Jul '08 | Simba | 17 |

